Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Food Testing Services Market

ID: MRFR/MRO/65004-HCR
200 Pages
Shubham Munde
Last Updated: April 09, 2026

Food Testing Services Market Research Report: Size, Share, Trend Analysis By End Use Outlook (Food Manufacturers, Food Retailers, Food Service Providers, Government Agencies, Research Institutions) By Application Outlook (Microbiological Testing, Chemical Testing, Nutritional Testing, Allergen Testing, Contaminant Testing) By Sample Type Outlook (Meat and Poultry, Dairy Products, Fruits and Vegetables, Grains and Cereals, Beverages) By Testing Method Outlook (Traditional Testing, Rapid Testing, Molecular Testing, Immunoassay Testing, Chromatography Testing) By Certification Type Outlook (ISO Certification, HACCP Certification, GMP Certification, Organic Certification, Non-GMO Certification) By Region (North America, Europe, APAC, South America, MEA) - Growth Outlook & Industry Forecast To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Food Testing Services Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Pharmaceutical, BY Application (USD Billion)
  49.     4.1.1 Microbiological Testing
  50.     4.1.2 Chemical Testing
  51.     4.1.3 Nutritional Testing
  52.     4.1.4 Allergen Testing
  53.     4.1.5 Contaminant Testing
  54.   4.2 Pharmaceutical, BY End Use (USD Billion)
  55.     4.2.1 Food Manufacturers
  56.     4.2.2 Food Retailers
  57.     4.2.3 Food Service Providers
  58.     4.2.4 Government Agencies
  59.     4.2.5 Research Institutions
  60.   4.3 Pharmaceutical, BY Sample Type (USD Billion)
  61.     4.3.1 Meat and Poultry
  62.     4.3.2 Dairy Products
  63.     4.3.3 Fruits and Vegetables
  64.     4.3.4 Grains and Cereals
  65.     4.3.5 Beverages
  66.   4.4 Pharmaceutical, BY Testing Method (USD Billion)
  67.     4.4.1 Traditional Testing
  68.     4.4.2 Rapid Testing
  69.     4.4.3 Molecular Testing
  70.     4.4.4 Immunoassay Testing
  71.     4.4.5 Chromatography Testing
  72.   4.5 Pharmaceutical, BY Certification Type (USD Billion)
  73.     4.5.1 ISO Certification
  74.     4.5.2 HACCP Certification
  75.     4.5.3 GMP Certification
  76.     4.5.4 Organic Certification
  77.     4.5.5 Non-GMO Certification
  78.   4.6 Pharmaceutical, BY Region (USD Billion)
  79.     4.6.1 North America
  80.       4.6.1.1 US
  81.       4.6.1.2 Canada
  82.     4.6.2 Europe
  83.       4.6.2.1 Germany
  84.       4.6.2.2 UK
  85.       4.6.2.3 France
  86.       4.6.2.4 Russia
  87.       4.6.2.5 Italy
  88.       4.6.2.6 Spain
  89.       4.6.2.7 Rest of Europe
  90.     4.6.3 APAC
  91.       4.6.3.1 China
  92.       4.6.3.2 India
  93.       4.6.3.3 Japan
  94.       4.6.3.4 South Korea
  95.       4.6.3.5 Malaysia
  96.       4.6.3.6 Thailand
  97.       4.6.3.7 Indonesia
  98.       4.6.3.8 Rest of APAC
  99.     4.6.4 South America
  100.       4.6.4.1 Brazil
  101.       4.6.4.2 Mexico
  102.       4.6.4.3 Argentina
  103.       4.6.4.4 Rest of South America
  104.     4.6.5 MEA
  105.       4.6.5.1 GCC Countries
  106.       4.6.5.2 South Africa
  107.       4.6.5.3 Rest of MEA
  108. 5 SECTION V: COMPETITIVE ANALYSIS
  109.   5.1 Competitive Landscape
  110.     5.1.1 Overview
  111.     5.1.2 Competitive Analysis
  112.     5.1.3 Market share Analysis
  113.     5.1.4 Major Growth Strategy in the Pharmaceutical
  114.     5.1.5 Competitive Benchmarking
  115.     5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  116.     5.1.7 Key developments and growth strategies
  117.       5.1.7.1 New Product Launch/Service Deployment
  118.       5.1.7.2 Merger & Acquisitions
  119.       5.1.7.3 Joint Ventures
  120.     5.1.8 Major Players Financial Matrix
  121.       5.1.8.1 Sales and Operating Income
  122.       5.1.8.2 Major Players R&D Expenditure. 2023
  123.   5.2 Company Profiles
  124.     5.2.1 Eurofins Scientific (LU)
  125.       5.2.1.1 Financial Overview
  126.       5.2.1.2 Products Offered
  127.       5.2.1.3 Key Developments
  128.       5.2.1.4 SWOT Analysis
  129.       5.2.1.5 Key Strategies
  130.     5.2.2 SGS SA (CH)
  131.       5.2.2.1 Financial Overview
  132.       5.2.2.2 Products Offered
  133.       5.2.2.3 Key Developments
  134.       5.2.2.4 SWOT Analysis
  135.       5.2.2.5 Key Strategies
  136.     5.2.3 Intertek Group plc (GB)
  137.       5.2.3.1 Financial Overview
  138.       5.2.3.2 Products Offered
  139.       5.2.3.3 Key Developments
  140.       5.2.3.4 SWOT Analysis
  141.       5.2.3.5 Key Strategies
  142.     5.2.4 Bureau Veritas (FR)
  143.       5.2.4.1 Financial Overview
  144.       5.2.4.2 Products Offered
  145.       5.2.4.3 Key Developments
  146.       5.2.4.4 SWOT Analysis
  147.       5.2.4.5 Key Strategies
  148.     5.2.5 ALS Limited (AU)
  149.       5.2.5.1 Financial Overview
  150.       5.2.5.2 Products Offered
  151.       5.2.5.3 Key Developments
  152.       5.2.5.4 SWOT Analysis
  153.       5.2.5.5 Key Strategies
  154.     5.2.6 TÜV SÜD AG (DE)
  155.       5.2.6.1 Financial Overview
  156.       5.2.6.2 Products Offered
  157.       5.2.6.3 Key Developments
  158.       5.2.6.4 SWOT Analysis
  159.       5.2.6.5 Key Strategies
  160.     5.2.7 Mérieux Nutrisciences (FR)
  161.       5.2.7.1 Financial Overview
  162.       5.2.7.2 Products Offered
  163.       5.2.7.3 Key Developments
  164.       5.2.7.4 SWOT Analysis
  165.       5.2.7.5 Key Strategies
  166.     5.2.8 Neogen Corporation (US)
  167.       5.2.8.1 Financial Overview
  168.       5.2.8.2 Products Offered
  169.       5.2.8.3 Key Developments
  170.       5.2.8.4 SWOT Analysis
  171.       5.2.8.5 Key Strategies
  172.     5.2.9 Food Safety Net Services (US)
  173.       5.2.9.1 Financial Overview
  174.       5.2.9.2 Products Offered
  175.       5.2.9.3 Key Developments
  176.       5.2.9.4 SWOT Analysis
  177.       5.2.9.5 Key Strategies
  178.   5.3 Appendix
  179.     5.3.1 References
  180.     5.3.2 Related Reports
  181. 6 LIST OF FIGURES
  182.   6.1 MARKET SYNOPSIS
  183.   6.2 NORTH AMERICA MARKET ANALYSIS
  184.   6.3 US MARKET ANALYSIS BY APPLICATION
  185.   6.4 US MARKET ANALYSIS BY END USE
  186.   6.5 US MARKET ANALYSIS BY SAMPLE TYPE
  187.   6.6 US MARKET ANALYSIS BY TESTING METHOD
  188.   6.7 US MARKET ANALYSIS BY CERTIFICATION TYPE
  189.   6.8 CANADA MARKET ANALYSIS BY APPLICATION
  190.   6.9 CANADA MARKET ANALYSIS BY END USE
  191.   6.10 CANADA MARKET ANALYSIS BY SAMPLE TYPE
  192.   6.11 CANADA MARKET ANALYSIS BY TESTING METHOD
  193.   6.12 CANADA MARKET ANALYSIS BY CERTIFICATION TYPE
  194.   6.13 EUROPE MARKET ANALYSIS
  195.   6.14 GERMANY MARKET ANALYSIS BY APPLICATION
  196.   6.15 GERMANY MARKET ANALYSIS BY END USE
  197.   6.16 GERMANY MARKET ANALYSIS BY SAMPLE TYPE
  198.   6.17 GERMANY MARKET ANALYSIS BY TESTING METHOD
  199.   6.18 GERMANY MARKET ANALYSIS BY CERTIFICATION TYPE
  200.   6.19 UK MARKET ANALYSIS BY APPLICATION
  201.   6.20 UK MARKET ANALYSIS BY END USE
  202.   6.21 UK MARKET ANALYSIS BY SAMPLE TYPE
  203.   6.22 UK MARKET ANALYSIS BY TESTING METHOD
  204.   6.23 UK MARKET ANALYSIS BY CERTIFICATION TYPE
  205.   6.24 FRANCE MARKET ANALYSIS BY APPLICATION
  206.   6.25 FRANCE MARKET ANALYSIS BY END USE
  207.   6.26 FRANCE MARKET ANALYSIS BY SAMPLE TYPE
  208.   6.27 FRANCE MARKET ANALYSIS BY TESTING METHOD
  209.   6.28 FRANCE MARKET ANALYSIS BY CERTIFICATION TYPE
  210.   6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
  211.   6.30 RUSSIA MARKET ANALYSIS BY END USE
  212.   6.31 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE
  213.   6.32 RUSSIA MARKET ANALYSIS BY TESTING METHOD
  214.   6.33 RUSSIA MARKET ANALYSIS BY CERTIFICATION TYPE
  215.   6.34 ITALY MARKET ANALYSIS BY APPLICATION
  216.   6.35 ITALY MARKET ANALYSIS BY END USE
  217.   6.36 ITALY MARKET ANALYSIS BY SAMPLE TYPE
  218.   6.37 ITALY MARKET ANALYSIS BY TESTING METHOD
  219.   6.38 ITALY MARKET ANALYSIS BY CERTIFICATION TYPE
  220.   6.39 SPAIN MARKET ANALYSIS BY APPLICATION
  221.   6.40 SPAIN MARKET ANALYSIS BY END USE
  222.   6.41 SPAIN MARKET ANALYSIS BY SAMPLE TYPE
  223.   6.42 SPAIN MARKET ANALYSIS BY TESTING METHOD
  224.   6.43 SPAIN MARKET ANALYSIS BY CERTIFICATION TYPE
  225.   6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  226.   6.45 REST OF EUROPE MARKET ANALYSIS BY END USE
  227.   6.46 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE
  228.   6.47 REST OF EUROPE MARKET ANALYSIS BY TESTING METHOD
  229.   6.48 REST OF EUROPE MARKET ANALYSIS BY CERTIFICATION TYPE
  230.   6.49 APAC MARKET ANALYSIS
  231.   6.50 CHINA MARKET ANALYSIS BY APPLICATION
  232.   6.51 CHINA MARKET ANALYSIS BY END USE
  233.   6.52 CHINA MARKET ANALYSIS BY SAMPLE TYPE
  234.   6.53 CHINA MARKET ANALYSIS BY TESTING METHOD
  235.   6.54 CHINA MARKET ANALYSIS BY CERTIFICATION TYPE
  236.   6.55 INDIA MARKET ANALYSIS BY APPLICATION
  237.   6.56 INDIA MARKET ANALYSIS BY END USE
  238.   6.57 INDIA MARKET ANALYSIS BY SAMPLE TYPE
  239.   6.58 INDIA MARKET ANALYSIS BY TESTING METHOD
  240.   6.59 INDIA MARKET ANALYSIS BY CERTIFICATION TYPE
  241.   6.60 JAPAN MARKET ANALYSIS BY APPLICATION
  242.   6.61 JAPAN MARKET ANALYSIS BY END USE
  243.   6.62 JAPAN MARKET ANALYSIS BY SAMPLE TYPE
  244.   6.63 JAPAN MARKET ANALYSIS BY TESTING METHOD
  245.   6.64 JAPAN MARKET ANALYSIS BY CERTIFICATION TYPE
  246.   6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  247.   6.66 SOUTH KOREA MARKET ANALYSIS BY END USE
  248.   6.67 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE
  249.   6.68 SOUTH KOREA MARKET ANALYSIS BY TESTING METHOD
  250.   6.69 SOUTH KOREA MARKET ANALYSIS BY CERTIFICATION TYPE
  251.   6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
  252.   6.71 MALAYSIA MARKET ANALYSIS BY END USE
  253.   6.72 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE
  254.   6.73 MALAYSIA MARKET ANALYSIS BY TESTING METHOD
  255.   6.74 MALAYSIA MARKET ANALYSIS BY CERTIFICATION TYPE
  256.   6.75 THAILAND MARKET ANALYSIS BY APPLICATION
  257.   6.76 THAILAND MARKET ANALYSIS BY END USE
  258.   6.77 THAILAND MARKET ANALYSIS BY SAMPLE TYPE
  259.   6.78 THAILAND MARKET ANALYSIS BY TESTING METHOD
  260.   6.79 THAILAND MARKET ANALYSIS BY CERTIFICATION TYPE
  261.   6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
  262.   6.81 INDONESIA MARKET ANALYSIS BY END USE
  263.   6.82 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE
  264.   6.83 INDONESIA MARKET ANALYSIS BY TESTING METHOD
  265.   6.84 INDONESIA MARKET ANALYSIS BY CERTIFICATION TYPE
  266.   6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
  267.   6.86 REST OF APAC MARKET ANALYSIS BY END USE
  268.   6.87 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE
  269.   6.88 REST OF APAC MARKET ANALYSIS BY TESTING METHOD
  270.   6.89 REST OF APAC MARKET ANALYSIS BY CERTIFICATION TYPE
  271.   6.90 SOUTH AMERICA MARKET ANALYSIS
  272.   6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
  273.   6.92 BRAZIL MARKET ANALYSIS BY END USE
  274.   6.93 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE
  275.   6.94 BRAZIL MARKET ANALYSIS BY TESTING METHOD
  276.   6.95 BRAZIL MARKET ANALYSIS BY CERTIFICATION TYPE
  277.   6.96 MEXICO MARKET ANALYSIS BY APPLICATION
  278.   6.97 MEXICO MARKET ANALYSIS BY END USE
  279.   6.98 MEXICO MARKET ANALYSIS BY SAMPLE TYPE
  280.   6.99 MEXICO MARKET ANALYSIS BY TESTING METHOD
  281.   6.100 MEXICO MARKET ANALYSIS BY CERTIFICATION TYPE
  282.   6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
  283.   6.102 ARGENTINA MARKET ANALYSIS BY END USE
  284.   6.103 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE
  285.   6.104 ARGENTINA MARKET ANALYSIS BY TESTING METHOD
  286.   6.105 ARGENTINA MARKET ANALYSIS BY CERTIFICATION TYPE
  287.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  288.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
  289.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE
  290.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY TESTING METHOD
  291.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY CERTIFICATION TYPE
  292.   6.111 MEA MARKET ANALYSIS
  293.   6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  294.   6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE
  295.   6.114 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE
  296.   6.115 GCC COUNTRIES MARKET ANALYSIS BY TESTING METHOD
  297.   6.116 GCC COUNTRIES MARKET ANALYSIS BY CERTIFICATION TYPE
  298.   6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  299.   6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE
  300.   6.119 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE
  301.   6.120 SOUTH AFRICA MARKET ANALYSIS BY TESTING METHOD
  302.   6.121 SOUTH AFRICA MARKET ANALYSIS BY CERTIFICATION TYPE
  303.   6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
  304.   6.123 REST OF MEA MARKET ANALYSIS BY END USE
  305.   6.124 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE
  306.   6.125 REST OF MEA MARKET ANALYSIS BY TESTING METHOD
  307.   6.126 REST OF MEA MARKET ANALYSIS BY CERTIFICATION TYPE
  308.   6.127 KEY BUYING CRITERIA OF PHARMACEUTICAL
  309.   6.128 RESEARCH PROCESS OF MRFR
  310.   6.129 DRO ANALYSIS OF PHARMACEUTICAL
  311.   6.130 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
  312.   6.131 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
  313.   6.132 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
  314.   6.133 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
  315.   6.134 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Billion)
  316.   6.135 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
  317.   6.136 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Billion)
  318.   6.137 PHARMACEUTICAL, BY SAMPLE TYPE, 2024 (% SHARE)
  319.   6.138 PHARMACEUTICAL, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion)
  320.   6.139 PHARMACEUTICAL, BY TESTING METHOD, 2024 (% SHARE)
  321.   6.140 PHARMACEUTICAL, BY TESTING METHOD, 2024 TO 2035 (USD Billion)
  322.   6.141 PHARMACEUTICAL, BY CERTIFICATION TYPE, 2024 (% SHARE)
  323.   6.142 PHARMACEUTICAL, BY CERTIFICATION TYPE, 2024 TO 2035 (USD Billion)
  324.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  325. 7 LIST OF TABLES
  326.   7.1 LIST OF ASSUMPTIONS
  327.     7.1.1
  328.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  329.     7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
  330.     7.2.2 BY END USE, 2025-2035 (USD Billion)
  331.     7.2.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  332.     7.2.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  333.     7.2.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  334.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  335.     7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
  336.     7.3.2 BY END USE, 2025-2035 (USD Billion)
  337.     7.3.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  338.     7.3.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  339.     7.3.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  340.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  341.     7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
  342.     7.4.2 BY END USE, 2025-2035 (USD Billion)
  343.     7.4.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  344.     7.4.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  345.     7.4.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  346.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  347.     7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
  348.     7.5.2 BY END USE, 2025-2035 (USD Billion)
  349.     7.5.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  350.     7.5.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  351.     7.5.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  352.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  353.     7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
  354.     7.6.2 BY END USE, 2025-2035 (USD Billion)
  355.     7.6.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  356.     7.6.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  357.     7.6.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  358.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  359.     7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
  360.     7.7.2 BY END USE, 2025-2035 (USD Billion)
  361.     7.7.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  362.     7.7.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  363.     7.7.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  364.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  365.     7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
  366.     7.8.2 BY END USE, 2025-2035 (USD Billion)
  367.     7.8.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  368.     7.8.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  369.     7.8.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  370.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  371.     7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
  372.     7.9.2 BY END USE, 2025-2035 (USD Billion)
  373.     7.9.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  374.     7.9.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  375.     7.9.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  376.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  377.     7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
  378.     7.10.2 BY END USE, 2025-2035 (USD Billion)
  379.     7.10.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  380.     7.10.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  381.     7.10.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  382.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  383.     7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
  384.     7.11.2 BY END USE, 2025-2035 (USD Billion)
  385.     7.11.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  386.     7.11.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  387.     7.11.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  388.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  389.     7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
  390.     7.12.2 BY END USE, 2025-2035 (USD Billion)
  391.     7.12.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  392.     7.12.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  393.     7.12.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  394.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  395.     7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
  396.     7.13.2 BY END USE, 2025-2035 (USD Billion)
  397.     7.13.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  398.     7.13.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  399.     7.13.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  400.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  401.     7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
  402.     7.14.2 BY END USE, 2025-2035 (USD Billion)
  403.     7.14.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  404.     7.14.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  405.     7.14.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  406.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  407.     7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
  408.     7.15.2 BY END USE, 2025-2035 (USD Billion)
  409.     7.15.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  410.     7.15.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  411.     7.15.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  412.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  413.     7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
  414.     7.16.2 BY END USE, 2025-2035 (USD Billion)
  415.     7.16.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  416.     7.16.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  417.     7.16.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  418.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  419.     7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
  420.     7.17.2 BY END USE, 2025-2035 (USD Billion)
  421.     7.17.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  422.     7.17.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  423.     7.17.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  424.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  425.     7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
  426.     7.18.2 BY END USE, 2025-2035 (USD Billion)
  427.     7.18.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  428.     7.18.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  429.     7.18.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  430.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  431.     7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
  432.     7.19.2 BY END USE, 2025-2035 (USD Billion)
  433.     7.19.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  434.     7.19.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  435.     7.19.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  436.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  437.     7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
  438.     7.20.2 BY END USE, 2025-2035 (USD Billion)
  439.     7.20.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  440.     7.20.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  441.     7.20.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  442.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  443.     7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
  444.     7.21.2 BY END USE, 2025-2035 (USD Billion)
  445.     7.21.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  446.     7.21.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  447.     7.21.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  448.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  449.     7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
  450.     7.22.2 BY END USE, 2025-2035 (USD Billion)
  451.     7.22.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  452.     7.22.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  453.     7.22.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  454.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  455.     7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
  456.     7.23.2 BY END USE, 2025-2035 (USD Billion)
  457.     7.23.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  458.     7.23.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  459.     7.23.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  460.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  461.     7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
  462.     7.24.2 BY END USE, 2025-2035 (USD Billion)
  463.     7.24.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  464.     7.24.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  465.     7.24.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  466.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  467.     7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
  468.     7.25.2 BY END USE, 2025-2035 (USD Billion)
  469.     7.25.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  470.     7.25.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  471.     7.25.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  472.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  473.     7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
  474.     7.26.2 BY END USE, 2025-2035 (USD Billion)
  475.     7.26.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  476.     7.26.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  477.     7.26.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  478.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  479.     7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
  480.     7.27.2 BY END USE, 2025-2035 (USD Billion)
  481.     7.27.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  482.     7.27.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  483.     7.27.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  484.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  485.     7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
  486.     7.28.2 BY END USE, 2025-2035 (USD Billion)
  487.     7.28.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  488.     7.28.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  489.     7.28.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  490.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  491.     7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
  492.     7.29.2 BY END USE, 2025-2035 (USD Billion)
  493.     7.29.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  494.     7.29.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  495.     7.29.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  496.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  497.     7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
  498.     7.30.2 BY END USE, 2025-2035 (USD Billion)
  499.     7.30.3 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  500.     7.30.4 BY TESTING METHOD, 2025-2035 (USD Billion)
  501.     7.30.5 BY CERTIFICATION TYPE, 2025-2035 (USD Billion)
  502.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  503.     7.31.1
  504.   7.32 ACQUISITION/PARTNERSHIP
  505.     7.32.1

Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Billion, 2025-2035)

  • Microbiological Testing
  • Chemical Testing
  • Nutritional Testing
  • Allergen Testing
  • Contaminant Testing

Pharmaceutical By End Use (USD Billion, 2025-2035)

  • Food Manufacturers
  • Food Retailers
  • Food Service Providers
  • Government Agencies
  • Research Institutions

Pharmaceutical By Sample Type (USD Billion, 2025-2035)

  • Meat and Poultry
  • Dairy Products
  • Fruits and Vegetables
  • Grains and Cereals
  • Beverages

Pharmaceutical By Testing Method (USD Billion, 2025-2035)

  • Traditional Testing
  • Rapid Testing
  • Molecular Testing
  • Immunoassay Testing
  • Chromatography Testing

Pharmaceutical By Certification Type (USD Billion, 2025-2035)

  • ISO Certification
  • HACCP Certification
  • GMP Certification
  • Organic Certification
  • Non-GMO Certification

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions